IMNM
NSCImmunome Inc.
Manufacturing•Pharmaceutical Preparation Manufacturing
Watchlists:
Last updated: Monday 21st July 2025
10.58
+0.13 (1.24%)
Prev Close:10.45
Open:10.49
Bid:10.6
Ask:11.15
52 Week Range
5.1516.81
Volume:998,590
Mkt Cap:731 M
51
MarketXLS Rank ®
Hold
Price Target
$12.17
+15.0%
Financial Statements
IMNM - Income Statement (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Invalid date | |
|---|---|---|---|---|---|---|
| Depreciation And Amortization | 2 M | 500000.0 | 400000.0 | 800000.0 | 800000.0 | |
| General And Administrative Expense | 33 M | 20 M | 14 M | 11 M | 5 M | |
| Gross Profit Margin (profit Margin After CGS) | 9 M | 14 M | ||||
| Interest Expense Non Operating | -13 M | -3 M | -5000.0 | 10000.0 | 38000.0 | |
| Interest Income Operating | 1000.0 | |||||
| Misc Other Special Charges | 503000.0 | -5 M | ||||
| Net Income (loss) | -293 M | -107 M | -37 M | -25 M | -18 M | |
| Net Income Common Stockholders | -293 M | -107 M | -38 M | -25 M | -18 M | |
| Net Income Continuous Operations | -293 M | -107 M | -37 M | -25 M | -18 M | |
| Net Non Operating Interest Income Expense | 13 M | 3 M | 5000.0 | -10000.0 | -38000.0 | |
| Non Recurring Operation Expense | 622000.0 | |||||
| Operating Income | -306 M | -110 M | -37 M | -25 M | -12 M | |
| Operating Income Before Depreciation (EBITDA) | -304 M | -109 M | -36 M | -24 M | -17 M | |
| Operating Expense | 315 M | 124 M | 37 M | 25 M | 12 M | |
| Other Gand A | 33 M | 20 M | 14 M | 11 M | 5 M | |
| Rent And Landing Fees | -500000.0 | -400000.0 | ||||
| Research Expense | 130 M | 23 M | 23 M | 14 M | 7 M | |
| Selling And Marketing Expense | 622000.0 | |||||
| Selling Expense | 622000.0 | |||||
| Total Income Available For Interest Expense (EBIT) | -306 M | -110 M | -37 M | -25 M | -18 M | |
| Total Revenues | 9 M | 14 M | ||||
| Total Expenses | 315 M | 124 M | 37 M | 25 M | 12 M | |
| Total Revenue | 9 M | 14 M | ||||
| Avgshs | 59 M | 20 M | 12 M | 12 M | 3 M | |
| Avgshsdt | 59 M | 20 M | 12 M | 12 M | 3 M | |
| Basiceps | -5.0 | -5.38 | -3.09 | -2.14 | -5.26 | |
| Basicepscont | -5.0 | -5.38 | -3.09 | -2.14 | -5.26 | |
| Depamor | 400000.0 | 800000.0 | 800000.0 | |||
| Dileps | -5.0 | -5.38 | -3.09 | -2.14 | -5.26 | |
| Dilepscont | -5.0 | -5.38 | -3.09 | -2.14 | ||
| Netincdisc | -293 M | -107 M | -37 M | -25 M | -18 M | |
| Othincexp | -81 M | -503000.0 | 6 M | |||
| Pretaxinc | -293 M | -26 M | -37 M | -25 M | -18 M | |
| Resdev | 130 M | 23 M | 23 M | 14 M | 7 M | |
| Sga | 33 M | 20 M | 14 M | 11 M | 5 M | |
| Shsout | 87 M | 87 M | 12 M | 12 M | 11 M | |
| Specincchg | -622000.0 |